⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CGTX News
Cognition Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
CGTX
Cognition Therapeutics Completes Meeting with FDA for Zervimesine (CT1812) in Dementia with Lewy Bodies with Psychosis
globenewswire.com
CGTX
Cognition Therapeutics Receives Second Philanthropic Donation to Extend Ongoing Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies
globenewswire.com
CGTX
Form 8-K
sec.gov
CGTX
Cognition Therapeutics Reports Financial Results for the First Quarter 2026 and Provides Business Update
globenewswire.com
CGTX
Cognition Therapeutics to Present at Needham Virtual Healthcare Conference
globenewswire.com
CGTX
Cognition Therapeutics CEO Issues Letter to Shareholders
globenewswire.com
CGTX
Form 8-K
sec.gov
CGTX
Cognition Therapeutics Reports Year End 2025 Financial Results and Provides Clinical Development Update
globenewswire.com
CGTX
Cognition Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results
globenewswire.com
CGTX